Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Añadir filtros








Intervalo de año
1.
Pakistan Journal of Pharmaceutical Sciences. 2018; 31 (3 Special): 1115-1118
en Inglés | IMEMR | ID: emr-198692

RESUMEN

Depression is a common affective disorder or mood disorder, which seriously affects people's physical and mental health and the quality of life. This study compared efficacy of escitalopram and fluoxetine on depression patients, and analyzed the inflammatory factors, serum homocysteine [Hcy] levels and the effects of adverse reactions, so as to provide reference for the clinical. The results showed that the total effective rate of the observation group [90.7%] was higher than that of the control group [80%], but the difference was not statistically significant [p>0.05]. The total score of Hamilton Depressive Scale [HAMD] and mood in the observation group was significantly lower than that in the control group after treatment. To sum up, escitalopram and fluoxetine are effective in the treatment of depressive patients, but escitalopram can significantly improve the patient's micro inflammation and depressive symptoms

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA